Search results
Results from the WOW.Com Content Network
The crab-eating macaque (Macaca fascicularis), also known as the long-tailed macaque or cynomolgus macaque, is a cercopithecine primate native to Southeast Asia. As a synanthropic species, the crab-eating macaque thrives near human settlements and in secondary forest.
The Nicobar long-tailed macaque is a frugivore, with its principal diet consisting of fruits and nuts. In common with other crab-eating macaques it turns to other sources of food—typically in the dry and early rainy tropical seasons—when the preferred fruits are unavailable.
This picture captured with my DSLR Full Frame Camera, NIKON D750. They are many visitor watching and giving food to the long tailed macaques. One of the monkey was enjoyed eating a fruit names "Durian", which is the king of fruits in Malaysia. The fruits was given by visitors.
Macaques are principally frugivorous (preferring fruit), although their diet also includes seeds, leaves, flowers, and tree bark. Some species such as the long-tailed macaque ( M. fascicularis ; also called the crab-eating macaque) will supplement their diets with small amounts of meat from shellfish, insects, and small mammals.
Indeed, the long-tailed macaque is now extinct in Bangladesh and fast disappearing from other locations, the report noted. Complicating matters is a lack of solid population data, as large-scale ...
Sir David Attenborough describes how long-tailed macaques barter with tourists by stealing phones in the latest edition of Planet Earth.. The Planet Earth team has filmed the adapted behaviour of ...
The Cercopithecinae are a subfamily of the Old World monkeys, which comprises roughly 71 species, including the baboons, the macaques, and the vervet monkeys.Most cercopithecine monkeys are limited to sub-Saharan Africa, although the macaques range from the far eastern parts of Asia through northern Africa, as well as on Gibraltar.
Without the long-tailed macaque, says the National Association of Biomedical Research, 53% of the 19,742 drugs and biologics currently in development “may never make it to market.”